The Methodist Hospital Research Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction

Phase 4

Recruiting

Conditions: Anterior Cruciate Ligament Injuries
Anterior Cruciate Ligament Tear
Anterior Cruciate Ligament Rupture

Interventions: Drug: Intraosseous Morphine

First Posted Date: 2024-07-19

Last Posted Date: 2024-11-01

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 84

Registration Number: NCT06511232

Locations: 🇺🇸
Houston Methodist Research Institute, Houston, Texas, United States

LSTR in Chevron Osteotomy

Not Applicable

Recruiting

Conditions: Bunion

Interventions: Procedure: Chevron osteotomy bunion surgery with lateral soft tissue release

First Posted Date: 2024-07-03

Last Posted Date: 2024-07-03

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 200

Registration Number: NCT06486753

Locations: 🇺🇸
Houston Methodist Research Institute, Houston, Texas, United States

IL-2 Plus Abatacept in FTD

Phase 1

Recruiting

Conditions: Frontotemporal Degeneration

Interventions: Drug: Abatacept plus Aldesleukin

First Posted Date: 2024-05-01

Last Posted Date: 2024-05-01

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 10

Registration Number: NCT06395038

Locations: 🇺🇸
Houston Methodist Research Institute, Houston, Texas, United States

Systemic and Central Inflammation in AD

Phase 2

Recruiting

Conditions: Alzheimer Disease

Interventions: Drug: 11C-ER176

First Posted Date: 2024-04-25

Last Posted Date: 2024-04-25

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 40

Registration Number: NCT06384378

Locations: 🇺🇸
Houston Methodist Research Institute, Houston, Texas, United States

Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty

Phase 4

Recruiting

Conditions: Infections
Ankle Arthritis

Interventions: Drug: Intravenous Vancomycin
Drug: Intraosseous Vancomycin Injection

First Posted Date: 2024-04-25

Last Posted Date: 2024-04-25

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 40

Registration Number: NCT06384651

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States

CBD for Pain Following Orthopedic Shoulder Surgery

Phase 1

Recruiting

Conditions: Shoulder Osteoarthritis
Rotator Cuff Injuries

Interventions: Drug: Placebo oral solution
Drug: Epidiolex

First Posted Date: 2024-04-24

Last Posted Date: 2024-10-14

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 80

Registration Number: NCT06381791

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States

Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity

Not Applicable

Recruiting

Conditions: Endoscopic Sleeve Gastroplasty
Obesity

Interventions: Procedure: Endoscopic Sleeve Gastroplasty (ESG)
Device: Apollo OverStitch endoscopic suturing device

First Posted Date: 2024-04-01

Last Posted Date: 2024-04-01

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 150

Registration Number: NCT06339320

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸
Houston Methodist Hospital - Sugarland, Sugar Land, Texas, United States

Protein Supplementation After ACL Surgery

Not Applicable

Recruiting

Conditions: ACL Reconstruction

Interventions: Dietary Supplement: Whey protein isolate
Dietary Supplement: Placebo
Dietary Supplement: Protein + BAA

First Posted Date: 2024-03-15

Last Posted Date: 2024-04-02

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 102

Registration Number: NCT06311058

Locations: 🇺🇸
Houston Methodist, Houston, Texas, United States

Study in ALS With Abatacept & IL-2

Phase 1

Active, not recruiting

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Drug: Abatacept Injection [Orencia] and Proleukin (aldesleukin)

First Posted Date: 2024-03-12

Last Posted Date: 2024-04-16

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 5

Registration Number: NCT06307301

Locations: 🇺🇸
Houston Methodist Research Institute, Houston, Texas, United States

Home Tele Rehabilitation Therapy for Vascular Dementia

Not Applicable

Not yet recruiting

Conditions: Dementia, Vascular
Stroke Sequelae

Interventions: Other: Home telerehabilitation therapy

First Posted Date: 2024-03-04

Last Posted Date: 2024-03-04

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 120

Registration Number: NCT06289569

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy